Effects of toluidine blue O (TBO)-photodynamic inactivation on community-associated methicillin-resistant Staphylococcus aureus isolates. 2017

Sung-Pin Tseng, and Wei-Chun Hung, and Hsiao-Jan Chen, and Yu-Tzu Lin, and Hung-Sih Jiang, and Hao-Chieh Chiu, and Po-Ren Hsueh, and Lee-Jene Teng, and Jui-Chang Tsai
Department of Medical Laboratory Science and Biotechnology, Kaohsiung Medical University, Kaohsiung, Taiwan.

OBJECTIVE Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) was recognized as a leading pathogen and has been shown to be genetically different from the health care-associated MRSA (HA-MRSA). Photodynamic therapy (PDT) is considered a potential alternative method for the treatment of resistant bacterial infections, but the effect of PDT on CA-MRSA is unknown. The purpose of this study was to compare the bactericidal effects of toluidine blue O (TBO) on CA-MRSA and HA-MRSA and investigate the photodynamic inactivation effects of TBO (TBO-PDI) against bacterial virulence factors. METHODS TBO-PDI effects were determined by measuring the survival fractions for four strains and bactericidal activities for 26 CA-MRSA isolates and 26 HA-MRSA isolates. The influences of TBO-PDI on DNA fragmentation and the activities of protease, lipase, staphylococcal α-hemolysin, and enterotoxin were studied. RESULTS TBO-PDI has effective bactericidal activity against both CA- and HA-MRSA. However, the bactericidal activity of TBO-PDI was significantly higher against HA-MRSA than CA-MRSA isolates. In addition, TBO-PDI treatment using a sublethal TBO concentration led to reduced production of several virulence factors, including protease, lipase, staphylococcal α-hemolysin, and enterotoxin. CONCLUSIONS Although TBO-PDI is slightly less effective against CA-MRSA than HA-MRSA isolates, TBO-PDI could reduce the production of virulence factors at a sublethal TBO concentration, which would be beneficial for treating CA-MRSA infections.

UI MeSH Term Description Entries
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections
D014048 Tolonium Chloride A phenothiazine that has been used as a hemostatic, a biological stain, and a dye for wool and silk. Tolonium chloride has also been used as a diagnostic aid for oral and gastric neoplasms and in the identification of the parathyroid gland in thyroid surgery. Toluidine Blue O,CI-52040,Toluidine Blue,Blue O, Toluidine,Blue, Toluidine,CI 52040,CI52040,Chloride, Tolonium
D017319 Photosensitizing Agents Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. Photosensitizer,Photosensitizers,Photosensitizing Agent,Photosensitizing Effect,Photosensitizing Effects,Agent, Photosensitizing,Agents, Photosensitizing,Effect, Photosensitizing,Effects, Photosensitizing
D017714 Community-Acquired Infections Any infection acquired in the community, that is, contrasted with those acquired in a health care facility (CROSS INFECTION). An infection would be classified as community-acquired if the patient had not recently been in a health care facility or been in contact with someone who had been recently in a health care facility. Community Acquired Infection,Community-Acquired Infection,Infections, Community-Acquired,Acquired Infection, Community,Acquired Infections, Community,Community Acquired Infections,Infection, Community Acquired,Infection, Community-Acquired,Infections, Community Acquired
D050296 Microbial Viability Ability of a microbe to survive under given conditions. This can also be related to a colony's ability to replicate. Bacterial Viability,Virus Viability,Bacteria Viability,Microbial Inactivation,Inactivation, Microbial,Viability, Bacteria,Viability, Bacterial,Viability, Microbial,Viability, Virus
D055624 Methicillin-Resistant Staphylococcus aureus A strain of Staphylococcus aureus that is non-susceptible to the action of METHICILLIN. The mechanism of resistance usually involves modification of normal or the presence of acquired PENICILLIN BINDING PROTEINS. MRSA,Methicillin Resistant Staphylococcus aureus
D037521 Virulence Factors Those components of an organism that determine its capacity to cause disease but are not required for its viability per se. Two classes have been characterized: TOXINS, BIOLOGICAL and surface adhesion molecules that effect the ability of the microorganism to invade and colonize a host. (From Davis et al., Microbiology, 4th ed. p486) Pathogenicity Factor,Pathogenicity Factors,Virulence Factor,Factor, Pathogenicity,Factor, Virulence,Factors, Pathogenicity,Factors, Virulence

Related Publications

Sung-Pin Tseng, and Wei-Chun Hung, and Hsiao-Jan Chen, and Yu-Tzu Lin, and Hung-Sih Jiang, and Hao-Chieh Chiu, and Po-Ren Hsueh, and Lee-Jene Teng, and Jui-Chang Tsai
September 2022, Photodiagnosis and photodynamic therapy,
Sung-Pin Tseng, and Wei-Chun Hung, and Hsiao-Jan Chen, and Yu-Tzu Lin, and Hung-Sih Jiang, and Hao-Chieh Chiu, and Po-Ren Hsueh, and Lee-Jene Teng, and Jui-Chang Tsai
February 2007, Emerging infectious diseases,
Sung-Pin Tseng, and Wei-Chun Hung, and Hsiao-Jan Chen, and Yu-Tzu Lin, and Hung-Sih Jiang, and Hao-Chieh Chiu, and Po-Ren Hsueh, and Lee-Jene Teng, and Jui-Chang Tsai
May 2008, Emergency medicine clinics of North America,
Sung-Pin Tseng, and Wei-Chun Hung, and Hsiao-Jan Chen, and Yu-Tzu Lin, and Hung-Sih Jiang, and Hao-Chieh Chiu, and Po-Ren Hsueh, and Lee-Jene Teng, and Jui-Chang Tsai
August 2007, North American journal of sports physical therapy : NAJSPT,
Sung-Pin Tseng, and Wei-Chun Hung, and Hsiao-Jan Chen, and Yu-Tzu Lin, and Hung-Sih Jiang, and Hao-Chieh Chiu, and Po-Ren Hsueh, and Lee-Jene Teng, and Jui-Chang Tsai
September 2006, Emerging infectious diseases,
Sung-Pin Tseng, and Wei-Chun Hung, and Hsiao-Jan Chen, and Yu-Tzu Lin, and Hung-Sih Jiang, and Hao-Chieh Chiu, and Po-Ren Hsueh, and Lee-Jene Teng, and Jui-Chang Tsai
August 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Sung-Pin Tseng, and Wei-Chun Hung, and Hsiao-Jan Chen, and Yu-Tzu Lin, and Hung-Sih Jiang, and Hao-Chieh Chiu, and Po-Ren Hsueh, and Lee-Jene Teng, and Jui-Chang Tsai
January 2012, Acta clinica Belgica,
Sung-Pin Tseng, and Wei-Chun Hung, and Hsiao-Jan Chen, and Yu-Tzu Lin, and Hung-Sih Jiang, and Hao-Chieh Chiu, and Po-Ren Hsueh, and Lee-Jene Teng, and Jui-Chang Tsai
December 2008, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia,
Sung-Pin Tseng, and Wei-Chun Hung, and Hsiao-Jan Chen, and Yu-Tzu Lin, and Hung-Sih Jiang, and Hao-Chieh Chiu, and Po-Ren Hsueh, and Lee-Jene Teng, and Jui-Chang Tsai
October 2009, Journal of clinical microbiology,
Sung-Pin Tseng, and Wei-Chun Hung, and Hsiao-Jan Chen, and Yu-Tzu Lin, and Hung-Sih Jiang, and Hao-Chieh Chiu, and Po-Ren Hsueh, and Lee-Jene Teng, and Jui-Chang Tsai
June 2005, Emerging infectious diseases,
Copied contents to your clipboard!